vidarabine has been researched along with Sensitivity and Specificity in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (20.83) | 18.2507 |
| 2000's | 12 (50.00) | 29.6817 |
| 2010's | 7 (29.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barré, L; Fillesoye, F; Gourand, F; Guillouet, S; Hovhannisyan, N; Ibazizene, M; Plancoulaine, B; Toutain, J; Valable, S | 1 |
| Daly, A; Kangarloo, SB; Ng, ES | 1 |
| Chennupati, S; Golla, M; Nalla, S; Rangasamy, M; Thappali, S; Vakkalanka, S; Veeraraghavan, S; Viswanadha, S | 1 |
| Aweeka, F; Dvorak, CC; Huang, L; Lizak, P; Long-Boyle, J | 1 |
| Derks, IA; Eldering, E; Hoogendoorn, M; Kater, AP; Laddach, N; Leeksma, AC; Loden-van Straaten, M; Luijks, DM; Moerland, PD; Navrkalova, V; Skowronska, A; Stankovic, T; te Raa, GD; Trbusek, M; van Oers, MH; Yigittop, H; Zenz, T | 1 |
| Barré, L; Dhilly, M; Guillouet, S; Hovhannisyan, N; Leporrier, M | 1 |
| Arnoulet, C; Béné, MC; Brumpt, C; Capiod, JC; de Carvalho Bittencourt, M; Degenne, M; Durrieu, F; Eghbali, H; Feugier, P; Feuillard, J; Garand, R; Geneviève, F; Kara-Terki, A; Kulhein, E; Maynadié, M; Ochoa-Noguera, ME; Plesa, A; Roussel, M; Truchan-Graczyk, M | 1 |
| Ueda, T; Yamauchi, T | 1 |
| Grdisa, M | 1 |
| Al-Ali, H; Brand, R; Deininger, M; Gentilini, C; Hegenbart, U; Krahl, R; Lange, T; Leiblein, S; Niederwieser, D; Petersdorf, E; Poenisch, W; Storb, RF; Uharek, L | 1 |
| Kalhorn, TF; McCune, JS; Ren, AG; Slattery, JT; Wang, J | 1 |
| Beijnen, JH; Hillebrand, MJ; Rosing, H; Silvertand, LH; van Maanen, MJ; Vazvaei, F; Weigl, P | 1 |
| Aly, F; Diehl, V; Rehwald, U; Schmitz, S; Steinmetz, T | 1 |
| Chao, NJ; Chute, JP; Dressman, HK; Ginsburg, GS; Marshall, D; Meadows, S; Muramoto, GG; Nevins, JR | 1 |
| Hillmen, P; Rawstron, AC; Sayala, HA | 1 |
| Lakeman, FD; Whitley, RJ | 1 |
| Canellakis, ZN; Costin, D; Degar, B; Drygas, JC; Mani, M; Morse, L; Newcomb, EW; Potmesil, M; Rosenberg, CR; Silber, R | 1 |
| Brasseur, P; Favennec, L; Marchand, J; Tharasse-Bloch, C | 1 |
| Calabrò, ML; Coppolino, S; Ficarra, P; Ficarra, R; Melardi, S; Semreen, M; Tommasini, S; Villari, A | 1 |
| Barth, S; Diehl, V; Engert, A; Oberhäuser, F; Pfitzner, T; Schinköthe, T; Schulz, H; Wittor, H | 1 |
| Du, M; Gandhi, V; Keating, MJ; Nowak, B; Paff, MT; Plunkett, W; Ramakrishna, P; Rodriguez, CO | 1 |
| Filippa, D; Glenn, M; Keenan, JR; Maslak, P; Noy, A; Rahman, ZU; Verma, R; Weiss, M; Zelenetz, AD | 1 |
| Cazin, B; Chevret, S; Delabarre, F; Leporrier, M; Levy, V; Porcher, R | 1 |
| Gandhi, V; Plunkett, W | 1 |
1 review(s) available for vidarabine and Sensitivity and Specificity
| Article | Year |
|---|---|
Minimal residual disease assessment in chronic lymphocytic leukaemia.
Topics: Alleles; Antibodies, Monoclonal; Antigens, CD19; CD5 Antigens; Combined Modality Therapy; Flow Cytometry; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasm, Residual; Polymerase Chain Reaction; Sensitivity and Specificity; Stem Cell Transplantation; Vidarabine | 2007 |
2 trial(s) available for vidarabine and Sensitivity and Specificity
| Article | Year |
|---|---|
Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs.
Topics: Antineoplastic Agents; B-Lymphocytes; Camptothecin; Cell Survival; Cells, Cultured; Chlorambucil; Genes, p53; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Mutation; Neoplasm Staging; Sensitivity and Specificity; Tumor Cells, Cultured; Vidarabine | 1994 |
Evaluating treatment strategies in chronic lymphocytic leukemia: use of quality-adjusted survival analysis.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Prednisone; Quality of Life; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Survival Analysis; Treatment Outcome; Vidarabine; Vincristine | 2001 |
21 other study(ies) available for vidarabine and Sensitivity and Specificity
| Article | Year |
|---|---|
[
Topics: Animals; Central Nervous System Neoplasms; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Heterografts; Histocytochemistry; Humans; Image Processing, Computer-Assisted; Lymphoma; Magnetic Resonance Imaging; Neoplasm Transplantation; Positron-Emission Tomography; Radiopharmaceuticals; Rats, Nude; Sensitivity and Specificity; Vidarabine | 2018 |
Improved quantitative method for fludarabine in human plasma by liquid chromatography and tandem mass spectrometry.
Topics: Antineoplastic Agents; Chromatography, Liquid; Cladribine; Drug Stability; Humans; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Vidarabine | 2013 |
Simultaneous quantification of idelalisib, fludarabine and lenalidomide in rat plasma by using high-performance liquid chromatography coupled with heated electrospray ionization tandem mass spectrometry.
Topics: Animals; Chromatography, High Pressure Liquid; Drug Stability; Lenalidomide; Male; Purines; Quinazolinones; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Thalidomide; Vidarabine | 2014 |
Simultaneous determination of fludarabine and clofarabine in human plasma by LC-MS/MS.
Topics: Adenine Nucleotides; Arabinonucleosides; Chromatography, Liquid; Clofarabine; Humans; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Vidarabine | 2014 |
Assessment of p53 and ATM functionality in chronic lymphocytic leukemia by multiplex ligation-dependent probe amplification.
Topics: Antineoplastic Agents; Ataxia Telangiectasia Mutated Proteins; Biological Assay; DNA Damage; Doxorubicin; Drug Resistance, Neoplasm; Epigenesis, Genetic; Gamma Rays; Gene Expression Regulation, Leukemic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Multiplex Polymerase Chain Reaction; Mutation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Sensitivity and Specificity; Tumor Suppressor Protein p53; Vidarabine | 2015 |
Comparative Analysis between [(18)F]Fludarabine-PET and [(18)F]FDG-PET in a Murine Model of Inflammation.
Topics: Animals; Fluorodeoxyglucose F18; Inflammation; Mice; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution; Vidarabine | 2016 |
Normal levels of peripheral CD19(+) CD5(+) CLL-like cells: toward a defined threshold for CLL follow-up -- a GEIL-GOELAMS study.
Topics: Adult; Aged; Aged, 80 and over; Antigens, CD19; B-Lymphocytes; CD5 Antigens; Cyclophosphamide; Female; Flow Cytometry; Follow-Up Studies; Humans; Immunophenotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Count; Male; Middle Aged; Neoplasm, Residual; Reference Values; ROC Curve; Sensitivity and Specificity; Vidarabine | 2011 |
Simple and sensitive method for quantification of fludarabine triphosphate intracellular concentration in leukemic cells using isocratic liquid chromatography.
Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Humans; Leukemia; Reproducibility of Results; Sensitivity and Specificity; Vidarabine | 2004 |
Sensitivity of B-cell chronic lymphocytic leukemia to Rituximab and Campath-1H and correlation with the expression of cell cycle regulatory proteins.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Apoptosis; B-Lymphocytes; Biomarkers, Tumor; Cell Cycle; Humans; In Vitro Techniques; Leukemia, Lymphocytic, Chronic, B-Cell; Microfilament Proteins; Muscle Proteins; Rituximab; Sensitivity and Specificity; Tumor Protein, Translationally-Controlled 1; Vidarabine | 2004 |
BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclosporine; Female; Fusion Proteins, bcr-abl; Hematopoietic Stem Cell Transplantation; Hematopoietic System; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Mycophenolic Acid; Neoplasm Recurrence, Local; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Sensitivity and Specificity; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2004 |
A highly sensitive high-performance liquid chromatography-mass spectrometry method for quantification of fludarabine triphosphate in leukemic cells.
Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Humans; Jurkat Cells; Leukemia; Mass Spectrometry; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Vidarabine | 2005 |
Simultaneous quantification of fludarabine and cyclophosphamide in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Cladribine; Cyclophosphamide; Humans; Molecular Structure; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Vidarabine | 2005 |
Sensitivity analysis of cost factors for various therapy options in the treatment of follicular lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Computer Simulation; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; European Union; Fees and Charges; Germany; Health Care Costs; Humans; Lymphoma, Follicular; Male; Models, Economic; Prednisone; Reproducibility of Results; Rituximab; Sensitivity and Specificity; Vidarabine; Vincristine | 2006 |
Gene expression signatures that predict radiation exposure in mice and humans.
Topics: Animals; Cyclophosphamide; DNA; DNA Damage; Dose-Response Relationship, Radiation; Environmental Exposure; Female; Gene Expression; Gene Expression Profiling; Gene Regulatory Networks; Genes; Humans; Leukocytes, Mononuclear; Mass Screening; Mice; Mice, Inbred C57BL; Oligonucleotide Array Sequence Analysis; Particle Accelerators; Radiation Dosage; Radiation Injuries, Experimental; Radiation, Ionizing; Sensitivity and Specificity; Single-Blind Method; Species Specificity; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2007 |
Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.
Topics: Base Sequence; Brain; DNA-Directed DNA Polymerase; DNA, Viral; Encephalitis, Viral; Herpes Simplex; Humans; Molecular Sequence Data; Polymerase Chain Reaction; Predictive Value of Tests; Sensitivity and Specificity; Simplexvirus; Vidarabine; Viral Envelope Proteins | 1995 |
Determination of sinefungin in rat plasma by high-performance liquid chromatography.
Topics: Adenosine; Animals; Antiprotozoal Agents; Chromatography, High Pressure Liquid; Injections, Intravenous; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Vidarabine | 1995 |
Determination of fludarabine in a pharmaceutical formulation by LC.
Topics: Antineoplastic Agents; Buffers; Calibration; Chromatography, High Pressure Liquid; Methanol; Pharmaceutical Preparations; Phosphates; Reproducibility of Results; Sensitivity and Specificity; Vidarabine | 1999 |
A real-time PCR assay for the quantification of residual malignant cells in B cell chronic lymphatic leukemia.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Blood Cells; Bone Marrow Cells; DNA Primers; DNA, Neoplasm; Gene Duplication; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Genes, Immunoglobulin; Hodgkin Disease; Humans; Immunization, Passive; Immunoglobulin Heavy Chains; Immunoglobulin Variable Region; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm, Residual; Neoplastic Stem Cells; Oligonucleotide Probes; Polymerase Chain Reaction; Reference Standards; Rituximab; Sensitivity and Specificity; Tumor Cells, Cultured; Vidarabine | 2000 |
High-performance liquid chromatography method for the determination and quantitation of arabinosylguanine triphosphate and fludarabine triphosphate in human cells.
Topics: Arabinonucleotides; Calibration; Chromatography, High Pressure Liquid; Guanosine Triphosphate; Humans; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tumor Cells, Cultured; Vidarabine | 2000 |
Clonotypic polymerase chain reaction confirms minimal residual disease in CLL nodular PR: results from a sequential treatment CLL protocol.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Clone Cells; Cyclophosphamide; Flow Cytometry; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Genes, Immunoglobulin; Immunoglobulin Heavy Chains; Immunoglobulin kappa-Chains; Immunoglobulin lambda-Chains; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemic Infiltration; Lymph Nodes; Neoplasm Proteins; Neoplasm, Residual; Polymerase Chain Reaction; Remission Induction; Sensitivity and Specificity; Treatment Outcome; Vidarabine | 2001 |
Cell cycle-specific metabolism of arabinosyl nucleosides in K562 human leukemia cells.
Topics: Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cell Cycle; Cytarabine; Deoxycytidine Kinase; Drug Synergism; G1 Phase; G2 Phase; Humans; Intracellular Fluid; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Metaphase; Nucleotides; S Phase; Sensitivity and Specificity; Tumor Cells, Cultured; Vidarabine | 1992 |